Advances in Cancer Therapies and Diagnostics

LIVE Symposium

March 18-19, 2025
11:00 AM - 3:00 PM ET

Cutting-edge research and innovations are transforming the cancer landscape. From genome editing to nanotechnologies, scientists across disciplines continue to push the envelope of oncology breakthroughs, leading to translational diagnostic discoveries and treatment advances.

In this two-day symposium brought to you by The Scientist, researchers will highlight basic, preclinical, and clinical cancer research involving new diagnostics and therapeutics.

Topics to be covered

Cell-based therapeutic engineering with new biomaterials
How genetic variation shapes normal physiology and cancer
Using prime and base editing technologies to investigate cancer mutations
Therapeutic applications of epigenetic regulation in cancer biology
Computational approaches that dissect therapeutic resistance and susceptibility
Elucidating the functions of receptor crosstalk in triple-positive breast cancer
Precision molecular diagnostics for pediatric malignancies

View Agenda

Francisco Sánchez-Rivera, PhD
Eisen & Chang Career Development Assistant Professor, Biology
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

David Liu, MD, MPH
Assistant Professor, Medicine
Dana-Farber Cancer Institute, Harvard Medical School
Associate Member, Broad Institute of Harvard and MIT

Omid Veiseh, PhD
Professor, Bioengineering
CPRIT Scholar in Cancer Research
Director, Rice Biotech Launch Pad
Rice University

Lei (Stanley) Qi, PhD
Associate Professor, Bioengineering
Stanford University

Rebecca B. Riggins, PhD
Associate Professor of Oncology,
Georgetown Lombardi Comprehensive Cancer Center

Jong-Sun Lee, PhD
Assistant Instructor
Joshua Mendell Lab
UT Southwestern Medical Center

Elaine Mardis, PhD
Co-executive Director
The Institute for Genomic Medicine at Nationwide Children’s Hospital
Professor of Pediatrics
The Ohio State University College of Medicine